{
  "id": "0f2c4e377e9151c6",
  "title": "Aspire Biopharma Announces Successful Pre - IND Meeting with FDA for High - Dose Sublingual Aspirin ( OTASA ) ",
  "description": "20260107T144500Z",
  "content": "",
  "source": "newjerseytelegraph.com",
  "source_url": "http://www.newjerseytelegraph.com/news/278795630/aspire-biopharma-announces-successful-pre-ind-meeting-with-fda-for-high-dose-sublingual-aspirin-otasa",
  "published_at": "20260107T144500Z",
  "fetched_at": "2026-01-08T00:23:56.998868+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "http://www.newjerseytelegraph.com/news/278795630/aspire-biopharma-announces-successful-pre-ind-meeting-with-fda-for-high-dose-sublingual-aspirin-otasa",
    "url_mobile": "",
    "title": "Aspire Biopharma Announces Successful Pre - IND Meeting with FDA for High - Dose Sublingual Aspirin ( OTASA ) ",
    "seendate": "20260107T144500Z",
    "socialimage": "",
    "domain": "newjerseytelegraph.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}